Search
Patexia Research
Case number 1:24-cv-00154

AbbVie Inc. v. Zenara Pharma Private Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jun 21, 2024 N/A CASE CLOSED per entry of D.I. 202 in Lead Civil Action 22-1423-JLH. (ceg) (Entered: 06/21/2024) (0)
Jun 21, 2024 9 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,690,845 B2; 11,690,854 B2. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 06/21/2024) (0)
Mar 5, 2024 8 SO ORDERED, re (7 in 1:24-cv-00153-JLH, 194 in 1:22-cv-01423-JLH, 7 in 1:24-cv-00154-JLH, 10 in 1:24-cv-00151-JLH, 10 in 1:24-cv-00152-JLH) Stipulation and Order regarding Consolidation for all purposes. Signed by Judge Jennifer L. Hall on 3/5/2024. Associated Cases: 1:22-cv-01423-JLH, 1:24-cv-00151-JLH, 1:24-cv-00152-JLH, 1:24-cv-00153-JLH, 1:24-cv-00154-JLH(ceg) (Entered: 03/05/2024) (8)
Mar 5, 2024 N/A Case associated with lead case: Create association to 1:22-cv-01423-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:22-cv-01423-JLH ONLY. (ceg) (Entered: 03/05/2024) (0)
Mar 1, 2024 7 STIPULATION and [Proposed] Order Regarding Consolidation by AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc.. (Dellinger, Megan) (Entered: 03/01/2024) (8)
Feb 23, 2024 6 Summonses Issued as to Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Limited on 2/23/2024. (Attachments: # 1 Summons Issued Zenara Pharma Private Limited)(jfm) (Entered: 02/23/2024) (0)
Feb 7, 2024 N/A Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:24-cv-00151-JLH, 1:24-cv-00152-JLH, 1:24-cv-00153-JLH, 1:24-cv-00154-JLH (rjb) (Entered: 02/07/2024) (0)
Feb 5, 2024 1 COMPLAINT for PATENT INFRINGEMENT filed against Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Limited ( Filing fee $ 405, receipt number ADEDC-4331015.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(smg) (Entered: 02/06/2024) (0)
Feb 5, 2024 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) (Entered: 02/06/2024) (3)
Feb 5, 2024 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: U.S. Patent No. 11,690,845: August 27, 2040; U.S. Patent No. 11,690,854: April 19, 2038. Thirty Month Stay Deadline: 1/23/2026. (smg) (Entered: 02/06/2024) (2)
Feb 5, 2024 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,690,845 B2; 11,690,854 B2. (smg) (Entered: 02/06/2024) (1)
Feb 5, 2024 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (smg) (Entered: 02/06/2024) (1)
Feb 5, 2024 N/A No Summons Issued. (smg) (Entered: 02/06/2024) (0)
Menu